Myelosuppression Effect Of Trimethoprim-Sulfamethoxazole Prophylaxis In Innate Immune Defect Patients: Retrospective Comparative Study

To indicate and report the frequency of myelosuppression effect seen with prophylactic dose of Trimethoprim-Sulfamethoxazole (TMP-SMX) in two groups: innate immune defect patients without bone marrow suppression, and immune competent patients for urinary tract infection (UTI)